Patents by Inventor Christopher E. HENRY

Christopher E. HENRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
    Publication number: 20230074115
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds, as well as to related intermediates, and crystal forms thereof, useful in such methods.
    Type: Application
    Filed: August 4, 2022
    Publication date: March 9, 2023
    Inventors: Raissa TREND, Michael DAPPEN, Christopher E. HENRY, Adam Aaron GOLDBLUM, James Bradley AGGEN, Ricardo Filipe de Jesus Gonçalves MENDONÇA, João Carlos Falcão SARDINHA
  • Synthesis of antibacterial aminoglycoside analogs
    Patent number: 11453658
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds, as well as to related intermediates, and crystal forms thereof, useful in such methods.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: September 27, 2022
    Assignee: CIPLA USA, INC.
    Inventors: Raissa Trend, Michael Dappen, Christopher E. Henry, Adam Aaron Goldblum, James Bradley Aggen, Ricardo Filipe de Jesus Gonçalves Mendonça, João Carlos Falcão Sardinha
  • SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
    Publication number: 20200317652
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds, as well as to related intermediates, and crystal forms thereof, useful in such methods.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 8, 2020
    Inventors: Raissa TREND, Michael DAPPEN, Christopher E. HENRY, Adam Aaron GOLDBLUM, James Bradley AGGEN, Ricardo Filipe de Jesus Gonçalves MENDONÇA, João Carlos Falcão SARDINHA
  • PLAZOMICIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190352426
    Abstract: The present invention provides anti-plazomicin antibodies and methods of use thereof, e.g., in determining levels of plazomicin in samples from human patients undergoing treatment with plazomicin. Such antibodies are useful, for example, in monitoring plazomicin levels during treatment for an infectious disease.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 21, 2019
    Applicant: Achaogen, Inc.
    Inventors: Kristina Oresic BENDER, Christopher E. HENRY, Richard THEOLIS, Shuang WU